國立高雄大學圖資館 |

Language: English

Back

Advances in cancer treatmentfrom sys...

Cavalcanti, Iago Dillion Lima.

Advances in cancer treatmentfrom systemic chemotherapy to targeted therapy /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Advances in cancer treatmentby Iago Dillion Lima Cavalcanti, Jose Cleberson Santos Soares.
Reminder of title:	from systemic chemotherapy to targeted therapy /
Author:	Cavalcanti, Iago Dillion Lima.
other author:	Soares, Jose Cleberson Santos.
Published:	Cham :Springer International Publishing :2021.
Description:	viii, 109 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	CancerTreatment.
Online resource:	https://doi.org/10.1007/978-3-030-68334-4
ISBN:	9783030683344$q(electronic bk.)

Advances in cancer treatmentfrom systemic chemotherapy to targeted therapy /
Cavalcanti, Iago Dillion Lima.

Advances in cancer treatmentfrom systemic chemotherapy to targeted therapy /[electronic resource] :by Iago Dillion Lima Cavalcanti, Jose Cleberson Santos Soares. - Cham :Springer International Publishing :2021. - viii, 109 p. :ill., digital ;24 cm.

This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment. We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells. The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment. This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology.

ISBN: 9783030683344$q(electronic bk.)

Standard No.: 10.1007/978-3-030-68334-4doiSubjects--Topical Terms:

252269
Cancer
--Treatment.

LC Class. No.: RC270.8 / .C35 2021

Dewey Class. No.: 616.99406

Advances in cancer treatmentfrom systemic chemotherapy to targeted therapy /
LDR:02742nmm a2200313 a 4500 001 600719
003 DE-He213
005 20210224093451.0
006 m d
007 cr nn 008maaau
008 211104s2021 sz s 0 eng d
020 $a 9783030683344$q(electronic bk.)
020 $a 9783030683337$q(paper)
024 7 $a 10.1007/978-3-030-68334-4 $2 doi
035 $a 978-3-030-68334-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.8 $b .C35 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99406 $2 23
090 $a RC270.8 $b .C376 2021
100 1 $a Cavalcanti, Iago Dillion Lima. $3 895373
245 1 0 $a Advances in cancer treatment $h [electronic resource] : $b from systemic chemotherapy to targeted therapy / $c by Iago Dillion Lima Cavalcanti, Jose Cleberson Santos Soares.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a viii, 109 p. : $b ill., digital ; $c 24 cm.
520 $a This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment. We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells. The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment. This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology.
650 0 $a Cancer $x Treatment. $3 252269
650 1 4 $a Oncology. $3 195181
650 2 4 $a Internal Medicine. $3 273839
650 2 4 $a Pharmacy. $3 218145
650 2 4 $a Cancer Research. $3 273660
700 1 $a Soares, Jose Cleberson Santos. $3 895374
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-68334-4
950 $a Medicine (SpringerNature-11650)